With a pending acquisition, though, investors didn't seem to care that much.
News & Analysis: CalAtlantic Group
The major indexes fell, Lennar and CalAtlantic announced a merger, and shares of Merck sank after it announced the withdrawal of a cancer drug application.
Lennar wants to shell over $9.3 billion for Cal Atlantic.
CalAtlantic's $0.75 per share result was slightly less than what the market wanted, but it wasn't enough to make investors worry.
These three growth stocks are cheap now, but they might not stay cheap for much longer.